Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taro Shuin

Showing results (121-130 of 180) with videos related to

Pageof 18
Sort By:
Medical Molecular Morphology|July 1, 2011
Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinomaNaoto Kuroda, Naoki Kanomata, Tadanori Yamaguchi, et al.
Digestive Diseases and Sciences|July 27, 2006
Emergency pancreatoduodenectomy for pancreatic metastasis from renal cell carcinoma in a patient with von Hippel-Lindau disease: a case reportHiromichi Maeda, Takehiro Okabayashi, Michiya Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profilingRyo Takata, Toyomasa Katagiri, Mitsugu Kanehira, et al.
Molecular and Cellular Biology|April 20, 2016
Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor αFumihiko Okumura, Keiji Uematsu, Stuart D Byrne, et al.
Scientific Reports|November 19, 2016
Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapyTaku Nakayama, Shimpei Otsuka, Tatsuya Kobayashi, et al.
Pathology International|January 9, 2010
Chromosomal abnormalities of clear cell renal cell carcinoma: frequent gain of chromosome 7Naoto Kuroda, Masato Tamura, Tomoyuki Shiotsu, et al.
Cancer Research|June 3, 2005
Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapyAkira Togashi, Toyomasa Katagiri, Shingo Ashida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progressionShingo Ashida, Mutsuo Furihata, Toyomasa Katagiri, et al.
Oncology Letters|July 12, 2017
Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse modelTakashi Karashima, Keiko Udaka, Mayumi Niimura, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 22, 2009
[Localized Fournier's gangrene of the penis: a case report]Takashi Anchi, Kenji Tamura, Keiji Inoue, et al.
Pageof 18

Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
Medical Molecular Morphology|July 1, 2011
Immunohistochemical application of S100A1 in renal oncocytoma, oncocytic papillary renal cell carcinoma, and two variants of chromophobe renal cell carcinomaNaoto Kuroda, Naoki Kanomata, Tadanori Yamaguchi, et al.
Digestive Diseases and Sciences|July 27, 2006
Emergency pancreatoduodenectomy for pancreatic metastasis from renal cell carcinoma in a patient with von Hippel-Lindau disease: a case reportHiromichi Maeda, Takehiro Okabayashi, Michiya Kobayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profilingRyo Takata, Toyomasa Katagiri, Mitsugu Kanehira, et al.
Molecular and Cellular Biology|April 20, 2016
Parallel Regulation of von Hippel-Lindau Disease by pVHL-Mediated Degradation of B-Myb and Hypoxia-Inducible Factor αFumihiko Okumura, Keiji Uematsu, Stuart D Byrne, et al.
Scientific Reports|November 19, 2016
Dormant cancer cells accumulate high protoporphyrin IX levels and are sensitive to 5-aminolevulinic acid-based photodynamic therapyTaku Nakayama, Shimpei Otsuka, Tatsuya Kobayashi, et al.
Pathology International|January 9, 2010
Chromosomal abnormalities of clear cell renal cell carcinoma: frequent gain of chromosome 7Naoto Kuroda, Masato Tamura, Tomoyuki Shiotsu, et al.
Cancer Research|June 3, 2005
Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapyAkira Togashi, Toyomasa Katagiri, Shingo Ashida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progressionShingo Ashida, Mutsuo Furihata, Toyomasa Katagiri, et al.
Oncology Letters|July 12, 2017
Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse modelTakashi Karashima, Keiko Udaka, Mayumi Niimura, et al.
Hinyokika Kiyo. Acta Urologica Japonica|April 22, 2009
[Localized Fournier's gangrene of the penis: a case report]Takashi Anchi, Kenji Tamura, Keiji Inoue, et al.
Pageof 18